ArticleWorld journal of gastrointestinal oncology2018

Comparison of efficacy and safety between standard-dose and modified-dose FOLFIRINOX as a first-line treatment of pancreatic cancer.

Huapyong Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.